Are you Dr. Gupta?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 94 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1331 N Elm St
Ste 200
Greensboro, NC 27401Phone+1 336-274-9617Fax+1 336-482-2177
Summary
- Dr. Ashok Gupta, MD is a board certified radiologist in Greensboro, North Carolina. He is currently licensed to practice medicine in North Carolina, South Carolina, and Virginia. He is affiliated with Boulder City Hospital, Summerlin Hospital Medical Center, and University Medical Center.
Education & Training
- University of MichiganResidency, Radiology-Diagnostic, 1997 - 2001
- University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 1996 - 1997
- University of Nebraska College of MedicineClass of 1996
Certifications & Licensure
- NM State Medical License 2013 - 2026
- VA State Medical License 2023 - 2026
- AZ State Medical License 2002 - 2025
- NC State Medical License 2023 - 2025
- NV State Medical License 2006 - 2025
- SC State Medical License 2023 - 2025
- UT State Medical License 2008 - 2024
- American Board of Radiology Diagnostic Radiology
- Join now to see all
Publications & Presentations
PubMed
- 352 citationsSurvival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving NivolumabDavid F. McDermott, Charles G. Drake, Mario Sznol, Toni K. Choueiri, John D. Powderly
Journal of Clinical Oncology. 2015-06-20 - 904 citationsOverall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell...Scott N. Gettinger, Leora Horn, Leena Gandhi, David R. Spigel, Scott J. Antonia
Journal of Clinical Oncology. 2015-04-20 - 3 citationsSurvival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab.Suzanne L Topalian, Mario Sznol, David F McDermott, Harriet M Kluger, Richard D Carvajal
Journal of Clinical Oncology. 2023-02-10
Press Mentions
- Health Care Quarterly’s 2020 Top DoctorsAugust 20th, 2020
- Top Doctors 2020August 1st, 2020